Compare FLGT & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLGT | BRSP |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.3M | 683.8M |
| IPO Year | 2016 | 2018 |
| Metric | FLGT | BRSP |
|---|---|---|
| Price | $27.16 | $5.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $28.33 | $6.00 |
| AVG Volume (30 Days) | 272.3K | ★ 721.2K |
| Earning Date | 11-07-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 10.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $315,549,000.00 | ★ $330,894,000.00 |
| Revenue This Year | $16.84 | N/A |
| Revenue Next Year | $9.74 | $4.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.61 | N/A |
| 52 Week Low | $14.57 | $4.16 |
| 52 Week High | $31.04 | $6.41 |
| Indicator | FLGT | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 74.07 |
| Support Level | $26.69 | $5.60 |
| Resistance Level | $31.04 | $5.97 |
| Average True Range (ATR) | 0.77 | 0.11 |
| MACD | -0.46 | 0.03 |
| Stochastic Oscillator | 10.80 | 98.09 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.